These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 3403099)

  • 1. Pharmacokinetics of aspirin and chloramphenicol in normal and leprotic patients before and after dapsone therapy.
    Garg SK; Kumar B; Shukla VK; Bakaya V; Lal R; Kaur S
    Int J Clin Pharmacol Ther Toxicol; 1988 Apr; 26(4):204-5. PubMed ID: 3403099
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma dapsone and its metabolite monoacetyldapsone levels in leprotic patients.
    Garg SK; Kumar B; Bakaya V; Lal R; Shukla VK; Kaur S
    Int J Clin Pharmacol Ther Toxicol; 1988 Nov; 26(11):552-4. PubMed ID: 3243659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Twenty five years follow up of MB leprosy patients retreated with a modified MDT regimen after a full course of dapsone mono-therapy.
    Jing Z; Zhang R; Zhou D; Chen J
    Lepr Rev; 2009 Jun; 80(2):170-6. PubMed ID: 19743621
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of clofazimine and dapsone on rifampicin (Lositril) pharmacokinetics in multibacillary and paucibacillary leprosy cases.
    Mehta J; Gandhi IS; Sane SB; Wamburkar MN
    Indian J Lepr; 1985; 57(2):297-310. PubMed ID: 4078356
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A retrospective study of the effect of modified multi-drug therapy in Nepali leprosy patients following the development of adverse effects due to dapsone.
    Sapkota BR; Shrestha K; Pandey B; Walker SL
    Lepr Rev; 2008 Dec; 79(4):425-8. PubMed ID: 19274989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A field trial among leprosy patients in Nigeria with depot injections of dapsone and monoacetyldapsone.
    Pieters FA; Woonink F; Zuidema J
    Int J Lepr Other Mycobact Dis; 1988 Mar; 56(1):10-20. PubMed ID: 3373080
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Vitamin E as protective agent against hemolysis in leprosy patients under dapsone treatment].
    Lardo MM; Díaz NB; Artaza JR; Carbia CD; Nazer R; Valdez R
    Medicina (B Aires); 1997; 57(2):150-4. PubMed ID: 9532824
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mortality due to dapsone hypersensitivity syndrome complicating multi-drug therapy for leprosy in Nepal.
    Pandey B; Shrestha K; Lewis J; Hawksworth RA; Walker SL
    Trop Doct; 2007 Jul; 37(3):162-3. PubMed ID: 17716505
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence of anemia in leprosy patients treated with dapsone.
    Puavilai S; Chutha S; Polnikorn N; Timpatanapong P; Tasanapradit P; Charuwichitratana S; Boonthanom A; Wongwaisayawan H
    J Med Assoc Thai; 1984 Jul; 67(7):404-7. PubMed ID: 6512448
    [No Abstract]   [Full Text] [Related]  

  • 10. [Dapsone-induced photodermatitis in a patient with leprosy].
    Fumey SM
    Z Hautkr; 1988 Jan; 63(1):53-4. PubMed ID: 3354248
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dapsone haemolysis in leprosy. A preliminary report.
    Menezes S; Rege VL; Sehgal VN
    Lepr India; 1981 Jan; 53(1):63-9. PubMed ID: 7218764
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dapsone-induced methemoglobinemia in leprosy patients.
    Kaur I; Mehta M; Agnihotri N; Dogra S; Ganguly NK
    Int J Lepr Other Mycobact Dis; 2001 Sep; 69(3):247-9. PubMed ID: 11875770
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of drug treatment on electroneurological measures of peripheral nerve function in leprosy patients.
    Mendis S; Somasiri KG; Chularatna W
    Ceylon Med J; 1993 Dec; 38(4):174-7. PubMed ID: 8143332
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dapsone in wheat flour as a possible method of therapy in leprosy. A laboratory report.
    Naik SS; Pandya SS
    Lepr India; 1977 Oct; 49(4):516-20. PubMed ID: 604659
    [No Abstract]   [Full Text] [Related]  

  • 15. Dapsone induced hypohaptoglobinemia in lepromatous leprosy patients.
    Sritharan V; Bharadwaj VP; Venkatesan K; Girdhar BK
    Int J Lepr Other Mycobact Dis; 1981 Sep; 49(3):307-10. PubMed ID: 7198620
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Secondary dapsone resistance in leprotic patients of the Shanghai district].
    Ji BH
    Zhonghua Yi Xue Za Zhi; 1983 Apr; 63(4):244-7. PubMed ID: 6413025
    [No Abstract]   [Full Text] [Related]  

  • 17. Vitamin E and dapsone-induced hemolysis.
    Kelly JW; Scott J; Sandland M; Van der Weyden MB; Marks R
    Arch Dermatol; 1984 Dec; 120(12):1582-4. PubMed ID: 6508329
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bioavailability of dapsone on oral administration of Dapsomine--a comparative evaluation.
    Venkatesan K; Chauhan SL; Girdhar A; Girdhar BK
    Indian J Lepr; 1993; 65(2):157-61. PubMed ID: 8345229
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Norethisterone and ethinyl estradiol kinetics during dapsone therapy.
    Joshi JV; Maitra A; Sankolli G; Bhatki S; Joshi UM
    J Assoc Physicians India; 1984 Feb; 32(2):191-3. PubMed ID: 6746515
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dapsone dependent nodular panniculitis.
    Uplekar MW; Antia NH
    Indian J Lepr; 1986; 58(2):286-90. PubMed ID: 3805799
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.